Drug Trial Radar · NCT05412394
Once Weekly Infant Corticosteroid Trial for DMD
Last checked: Nov 20, 2026Latest source record: Aug 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
26
Planned (sponsor's estimate)
Start
Apr 30, 2021
Primary completion
Aug 2028
Study completion Dec 2028
Sponsor
- Lead sponsor
- Anne M. ConnollyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Children's Hospital Medical Center, Cincinnati; Muscular Dystrophy Association; University of Texas; Virginia Commonwealth University; Ann & Robert H Lurie Children's Hospital of Chicago
- First posted
- Jun 9, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 1 month, up to 30 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The hypothesis tested here is that a lower dose of intermittent oral corticosteroids (5mg/kg/week) will be equally effective to the 10mg/kg/week dose.
Conditions
- Duchenne Muscular Dystrophy
Interventions
PrednisoloneDrug
Liquid, 5mg/kg per week, for one year
Primary outcomes
What the sponsor says the trial is designed to measure.
- The change from baseline to 24 months for the Gross Motor Scaled Score.Time frame: Baseline visit to 24 month visit
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Lurie Children's Hospital of Chicago
Chicago, Illinois · Recruiting
University of Cincinnati
Cincinnati, Ohio · Recruiting
Nationwide Children's Hospital
Columbus, Ohio · Recruiting
University of Texas Southwestern
Dallas, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.